$599

Sanofi Appoints New EVP; CVS Expands GLP-1RA Support; COUR Closes $50M Series B; June CHMP Agenda

A series of cardiometabolic-related news items has been observed from Sanofi, CVS Health, COUR Pharma, and EMA. Below, FENIX provides highlights and insights for the respective news items.

This content is for Read Less members only.
Already a member? Log in here